Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

Acalabrutinib granted Breakthrough Therapy Designation by US FDA for the treatment of patients with mantle cell lymphoma
1 August 2017
Imfinzi granted Breakthrough Therapy Designation by US FDA for patients with locally-advanced unresectable non-small cell lung cancer
31 July 2017
Tagrisso significantly improves progression-free survival in the Phase III FLAURA trial for lung cancer
27 July 2017
AstraZeneca reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer
27 July 2017
AstraZeneca and Merck establish strategic oncology collaboration
27 July 2017
H1 2017 Results
27 July 2017
Faslodex receives EU approval as first-line therapy for advanced breast cancer
26 July 2017
Kyntheum approved in the EU for the treatment of adults with moderate-to-severe plaque psoriasis
20 July 2017
Faslodex (fulvestrant) receives positive CHMP opinion for use in 1st-line hormone receptor-positive advanced breast cancer
23 June 2017
AstraZeneca presents new data underpinning safety profile and real-world CV outcomes of Farxiga at ADA 2017
12 June 2017

<
47
48
49
50
51
52
53
111
>

All of our latest press releases and articles are available to explore